Related Experiment Video
Updated: Aug 18, 2026

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
Published on: March 11, 2014
Differences in Smad4 expression in human papillomavirus type 16-positive and human papillomavirus type 16-negative
Adriana Báez1, Alan Cantor, Sharon Fonseca
1Department of Otolaryngology-Head and Neck Surgery, University of Puerto Rico School of Medicine, San Juan, Puerto Rico. abaez@rcm.upr.edu
Abstract:
The SMADs are a group of interrelated proteins that mediate transforming growth factor beta (TGF-beta) signaling. Upon TGF-beta binding the TGF-beta type I receptor phosphorylates Smad2 and Smad3, which then complex with Smad4 and translocate to the nucleus, with subsequent activation of target genes. Disruption of TGF-beta signaling is thought to contribute to the development of head and neck squamous cell carcinomas (HNSCC). Alterations in the function of the DPC4/Smad4 tumor suppressor gene have been found to inactivate TGF-beta signaling in several tumor types. For example, DPC4/Smad4 is lost or mutated in colorectal, pancreatic, and esophageal cancers. In addition, DPC4/Smad4 transcriptional activity and TGF-beta ability to inhibit DNA synthesis is blocked by the E7 protein of the human papillomavirus type 16 (HPV16) in cervical carcinoma cell lines. HPV16 infection is a risk factor for the development of a subset of HNSCC. This study was undertaken to investigate a potential correlation between expression of components of the TGF-beta signaling pathway and HPV16 status in HNSCC tumors. We examined the expression of TGF-beta signaling proteins Smad2, Smad2-P, and Smad4 by immunohistochemistry in 27 HPV16-negative and 16 HPV16-positive HNSCCs. We compared the expression patterns and assessed their relationship to HPV16 status. No significant differences were detected between HPV16-positive and HPV16-negative tumors in the expression of Smad2 and Smad2-P. Smad4 expression, however, was decreased in 56% of the HPV16-positive tumors and in 39% of HPV16-negative tumors. This difference was statistically significant (P = 0.01) suggesting that loss of Smad4 expression may be involved in HPV16-induced carcinogenesis of HNSCC.
Insights
Head and neck squamous cell carcinomas (HNSCC) involve transforming growth factor beta (TGF-beta) signaling. This study found significantly lower Smad4 expression in HPV16-positive HNSCC tumors, suggesting a role in HPV16-induced carcinogenesis.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Transforming growth factor beta (TGF-beta) signaling, mediated by SMAD proteins, is crucial for cellular regulation.
- Disruption of TGF-beta signaling is implicated in head and neck squamous cell carcinomas (HNSCC).
- The tumor suppressor gene DPC4/Smad4 is vital for TGF-beta signaling and frequently altered in various cancers; HPV16 may interfere with its function.
Purpose of the Study:
- To investigate the correlation between TGF-beta signaling pathway components (Smad2, Smad2-P, Smad4) and HPV16 status in HNSCC.
- To determine if HPV16 infection influences the expression of key SMAD proteins in HNSCC development.
Main Methods:
- Immunohistochemistry was used to examine the expression of Smad2, phosphorylated Smad2 (Smad2-P), and Smad4.
- Expression patterns were analyzed in 43 HNSCC tumors, categorized as HPV16-negative (n=27) and HPV16-positive (n=16).
- Statistical analysis compared protein expression levels between HPV16-positive and HPV16-negative tumor groups.
Main Results:
- No significant differences in Smad2 or Smad2-P expression were observed between HPV16-positive and HPV16-negative HNSCC tumors.
- A statistically significant decrease in Smad4 expression was found in 56% of HPV16-positive tumors compared to 39% of HPV16-negative tumors (P = 0.01).
Conclusions:
- Loss of Smad4 expression is significantly associated with HPV16-positive HNSCC.
- These findings suggest that reduced Smad4 expression may play a role in HPV16-induced head and neck squamous cell carcinoma development.
More Related Videos
07:43Four-color Fluorescence Immunohistochemistry of T-cell Subpopulations in Archival Formalin-fixed, Paraffin-embedded Human Oropharyngeal Squamous Cell Carcinoma Samples
Published on: July 29, 2017
06:57Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
Published on: June 14, 2019